Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
SXT
|
Sharad P Jain
Director |
BUY
Open market or private purchase
|
Direct | 400 Added 44.4% |
$31,200
$78.0 p/Share
|
Mar 01
2022 |
HOMB
|
Russell Davis Carter Iii
Centennial Bank Regional Pres. |
BUY
Open market or private purchase
|
Direct | 500 Added 2.6% |
$11,185
$22.37 p/Share
|
Mar 01
2022 |
HOMB
|
Jack Engelkes
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 6,000 Added 3.78% |
$102,720
$17.12 p/Share
|
Mar 01
2022 |
HIW
|
Brendan C Maiorana
EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,107 Reduced 2.81% |
-
|
Mar 01
2022 |
HIW
|
Brendan C Maiorana
EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct | 20,064 Added 33.76% |
-
|
Mar 01
2022 |
HIW
|
Brendan C Maiorana
EVP, CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 506 Reduced 1.32% |
-
|
Mar 01
2022 |
HIW
|
Charles Albert Anderson |
BUY
Grant, award, or other acquisition
|
Direct | 2,085 Added 11.93% |
-
|
Mar 01
2022 |
HIW
|
Gene H Anderson |
BUY
Grant, award, or other acquisition
|
Direct | 2,085 Added 2.51% |
-
|
Mar 01
2022 |
HIW
|
Carlos E Evans |
BUY
Grant, award, or other acquisition
|
Direct | 2,085 Added 5.04% |
-
|
Mar 01
2022 |
HIW
|
David John Hartzell |
BUY
Grant, award, or other acquisition
|
Direct | 2,085 Added 6.95% |
-
|
Mar 01
2022 |
HIW
|
Anne H Lloyd |
BUY
Grant, award, or other acquisition
|
Direct | 2,085 Added 17.65% |
-
|
Mar 01
2022 |
HIW
|
Thomas P Anderson |
BUY
Grant, award, or other acquisition
|
Direct | 2,085 Added 18.55% |
-
|
Mar 01
2022 |
HIW
|
David L Gadis |
BUY
Grant, award, or other acquisition
|
Direct | 2,085 Added 32.65% |
-
|
Mar 01
2022 |
HIW
|
Theodore J Klinck
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,460 Reduced 4.48% |
-
|
Mar 01
2022 |
HIW
|
Theodore J Klinck
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 60,816 Added 19.2% |
-
|
Mar 01
2022 |
HIW
|
Theodore J Klinck
President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 3,050 Reduced 1.25% |
-
|
Mar 01
2022 |
HIW
|
Jeffrey Douglas Miller
EVP, General Counsel & Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 3,332 Reduced 2.77% |
-
|
Mar 01
2022 |
HIW
|
Jeffrey Douglas Miller
EVP, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct | 14,552 Added 10.78% |
-
|
Mar 01
2022 |
HIW
|
Jeffrey Douglas Miller
EVP, General Counsel & Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,566 Reduced 1.34% |
-
|
Mar 01
2022 |
HIW
|
Brian M Leary
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,070 Reduced 6.89% |
-
|
Mar 01
2022 |
HIW
|
Brian M Leary
EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct | 19,816 Added 21.22% |
-
|
Mar 01
2022 |
HIW
|
Brian M Leary
EVP & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 2,347 Reduced 3.43% |
-
|
Mar 01
2022 |
KRTX
|
Stephen K. Brannan
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 7,728 Reduced 38.2% |
$829,833
$107.38 p/Share
|
Mar 01
2022 |
KRTX
|
Stephen K. Brannan
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,228 Added 33.58% |
$74,971
$7.33 p/Share
|
Mar 01
2022 |
SAM
|
Lesya Lysyj
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 658 Added 11.18% |
-
|
Mar 01
2022 |
SAM
|
Frank H. Smalla
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 756 Added 4.5% |
-
|
Mar 01
2022 |
SAM
|
Frank H. Smalla
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 137 Reduced 0.89% |
$52,534
$383.46 p/Share
|
Mar 01
2022 |
SAM
|
David A Burwick
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 5,216 Added 10.18% |
-
|
Mar 01
2022 |
SAM
|
David A Burwick
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 652 Reduced 1.57% |
$250,016
$383.46 p/Share
|
Mar 01
2022 |
SAM
|
Matthew Donal Murphy
CAO & VP of Finance |
BUY
Grant, award, or other acquisition
|
Direct | 783 Added 23.73% |
-
|
Mar 01
2022 |
SAM
|
Carolyn L. O'Boyle
Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct | 565 Added 16.94% |
-
|
Mar 01
2022 |
SAM
|
Carolyn L. O'Boyle
Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 224 Reduced 9.22% |
$85,895
$383.46 p/Share
|
Mar 01
2022 |
SAM
|
John C Geist
Chief Sales Officer |
SELL
Open market or private sale
|
Direct | 456 Reduced 8.76% |
$176,983
$388.12 p/Share
|
Mar 01
2022 |
SAM
|
John C Geist
Chief Sales Officer |
BUY
Grant, award, or other acquisition
|
Direct | 756 Added 12.68% |
-
|
Mar 01
2022 |
SAM
|
David L. Grinnell
Vice President of Brewing |
SELL
Payment of exercise price or tax liability
|
Direct | 75 Reduced 4.45% |
-
|
Mar 01
2022 |
SAM
|
Quincy B Troupe
Senior VP, Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct | 135 Reduced 2.8% |
-
|
Mar 01
2022 |
SAM
|
Tara L. Heath
Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 783 Added 23.1% |
-
|
Mar 01
2022 |
SAM
|
Tara L. Heath
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 76 Reduced 4.0% |
$29,143
$383.46 p/Share
|
Mar 01
2022 |
AGO
|
Howard Albert
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 60,000 Reduced 36.16% |
$3,567,600
$59.46 p/Share
|
Mar 01
2022 |
AGO
|
Robert Bailenson
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 33,417 Reduced 9.85% |
$1,968,261
$58.9 p/Share
|
Mar 01
2022 |
AQUA
|
Herve Fages
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,235 Reduced 2.9% |
$52,685
$42.66 p/Share
|
Mar 01
2022 |
SRCL
|
Daniel Ginnetti
EVP INTERNATIONAL |
SELL
Payment of exercise price or tax liability
|
Direct | 412 Reduced 3.69% |
$23,999
$58.25 p/Share
|
Mar 01
2022 |
SRCL
|
Daniel Ginnetti
EVP INTERNATIONAL |
BUY
Exercise of conversion of derivative security
|
Direct | 1,430 Added 11.35% |
-
|
Mar 01
2022 |
SRCL
|
Richard J Hoffman
SVP & CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 884 Reduced 6.93% |
$51,493
$58.25 p/Share
|
Mar 01
2022 |
SRCL
|
Richard J Hoffman
SVP & CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 2,750 Added 18.06% |
-
|
Mar 01
2022 |
APLS
|
Federico Grossi
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 375 Reduced 0.34% |
$16,324
$43.53 p/Share
|
Mar 01
2022 |
PRI
|
Gregory C. Pitts
Executive VP and COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,667 Reduced 11.66% |
$216,527
$129.89 p/Share
|
Mar 01
2022 |
PRI
|
Gregory C. Pitts
Executive VP and COO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,528 Reduced 8.93% |
$198,472
$129.89 p/Share
|
Mar 01
2022 |
PRI
|
Gregory C. Pitts
Executive VP and COO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,896 Added 22.88% |
-
|
Mar 01
2022 |
PRI
|
Gregory C. Pitts
Executive VP and COO |
BUY
Grant, award, or other acquisition
|
Direct | 4,472 Added 20.73% |
-
|
Mar 01
2022 |